Intra-Class Comparisons Could Help Drugs With Safety Issues – FDA’s Temple

Drugs with potential safety concerns could benefit from demonstrating an efficacy advantage over other agents in the same class, FDA Center for Drug Evaluation & Research Office of Medical Policy Director Robert Temple suggested June 28